CORRESP Filing
Aspira Women's Health Inc.
Date: May 6, 2025 · CIK: 0000926617 · Accession: 0001641172-25-008891
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-286561
Letter
ASPIRA WOMEN'S HEALTH INC.
Bee Caves Road, Building III, Suite 100
Austin, Texas 78738
May 6, 2025
VIA EDGAR
United States Securities and Exchange Commission
F Street, N.E.
Washington, D.C. 20549
Attention: Joshua Gorsky
Re: Aspira Women's Health Inc.
Registration Statement on Form S-1
Filed May 6, 2025
File No. 333-286561
Ladies and Gentlemen:
Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Aspira Women's Health Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above (the "Registration Statement") be accelerated so that it becomes effective at 9:00 a.m., Eastern Time, on Wednesday May 7, 2025, or as soon thereafter as possible.
Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request.
Sincerely,
ASPIRA WOMEN'S HEALTH INC.
Show Raw Text
CORRESP 1 filename1.htm ASPIRA WOMEN'S HEALTH INC. 12117 Bee Caves Road, Building III, Suite 100 Austin, Texas 78738 May 6, 2025 VIA EDGAR United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Joshua Gorsky Re: Aspira Women's Health Inc. Registration Statement on Form S-1 Filed May 6, 2025 File No. 333-286561 Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities Act of 1933, as amended, Aspira Women's Health Inc. (the "Company") respectfully requests that the effective date of the registration statement referred to above (the "Registration Statement") be accelerated so that it becomes effective at 9:00 a.m., Eastern Time, on Wednesday May 7, 2025, or as soon thereafter as possible. Please notify Jeffrey Fessler of Sheppard, Mullin, Richter & Hampton LLP, counsel to the Company, at (212) 634-3067 as soon as possible as to the time the Registration Statement has been declared effective pursuant to this acceleration request. Sincerely, ASPIRA WOMEN'S HEALTH INC. By: /s/ Michael Buhle Name: Michael Buhle Title: Chief Executive Officer - 1 -